ESC 365 - Mitral and Tricuspid regurgitation in Heart Failure: Time to treat

Open Access

Mitral and Tricuspid regurgitation in Heart Failure: Time to treat

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Multidisciplinary Interventions

Session type: Industry Q&A session

Sponsored by ABBOTT

Date: 31 August 2020

Time: 18:30 - 19:30

Session

This content is currently on OPEN ACCESS

Sign in to view the resources

6 presentations in this session

Introduction.

Speaker: Professor A. Coats (Coventry, GB)

Treating Valvular Diseases in Heart Failure: Time is key.

Speaker: Professor M. Senni (Bergamo, IT)

Transcatheter Mitral Valve Therapy: New standard of care in Secondary Mitral Regurgitation.

Speaker: Professor P. Guerin (Nantes, FR)

Burden of Tricuspid Regurgitation in Heart failure.

Speaker: Professor Y. Topilsky (Tel Aviv, IL)

Treating Tricuspid Regurgitation in Heart Failure: Who can benefit from transcatheter therapy.

Speaker: Professor G. Nickenig (Bonn, DE)

Take-Home messages.

5 speakers from this session

Professor Andrew Coats

University of Warwick, Coventry (United Kingdom of Great Britain & Northern Ireland)

88 presentations

4 followers

Professor Michele Senni

Papa Giovanni XXIII Hospital, Bergamo (Italy)

36 presentations

0 follower

Professor Patrice Guerin

University Hospital of Nantes, Nantes (France)

0 follower

Professor Yan Topilsky

Sourasky Medical Center, Tel Aviv (Israel)

3 presentations

0 follower

Professor Georg Nickenig

Heartcenter Bonn, University Hospital Bonn, Bonn (Germany)

15 presentations

0 follower

This platform is supported by